Key Highlights
- Major Series A Funding: Bright Uro announces $23M Series A financing, led by Laborie Medical Technologies.
- Innovative Glean™ System: The funding will support FDA clearance and the U.S. launch of the Glean™ Urodynamics System, a wireless, catheter-free diagnostic tool for LUTS.
- Experienced Leadership Team: The appointment of Suranjan Roychowdhury and Casey Kanel strengthens the executive team, enhancing product development and commercial strategy.
Source: Business Wire
Notable Quotes
- “The Glean system is a very novel technology. This investment furthers our commitment to preserve and restore human dignity while improving patient access and outcomes.” – Michael Frazzette, President & CEO at Laborie
- “I am so proud of our team for achieving this incredible milestone! In just 15 months since securing an exclusive IP license from the Cleveland Clinic, we have built, tested, and manufactured not one device, but a highly complex system, including single-use disposable sensors, male and female insertion tools, a reusable uroflowmeter, and multiple software apps. At Bright Uro, our people are our most important asset.” – Derek Herrera, Founder and CEO at Bright Uro
SoH's Take
Bright Uro’s Series A funding round, led by Laborie Medical Technologies, marks a significant milestone in the advancement of urological care. The $23 million investment underscores the healthcare industry’s commitment to innovative solutions for managing lower urinary tract symptoms (LUTS). The Glean™ Urodynamics System, with its wireless, catheter-free approach, represents a paradigm shift in urodynamics, offering a more patient-friendly and efficient diagnostic tool. This technology promises to enhance clinical decision-making while significantly improving patient comfort. The strategic appointments of Suranjan Roychowdhury and Casey Kanel further signal Bright Uro’s readiness to navigate the complex landscape of medical device innovation and market introduction. This development is a testament to the potential of technology-driven solutions in transforming patient care and clinical outcomes in urology.
